This is intro header
- Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Quisque sed felis. Aliquam sit amet felis. Mauris semper, velit semper laoreet dictum, quam diam dictum urna, nec placerat elit nisl in quam. Etiam augue pede, molestie eget, rhoncus at, convallis ut, eros. Aliquam pharetra. Nulla in tellus eget
Recent Blog Posts
-
African Nations’ Experience With ABC Prevention Method ‘Mixed’ As Reported At AIDS Conference
African nations on Monday at the XVI International AIDS Conference in Toronto reported a "distinctly conflicting report card" about their experiences with the HIV/AIDS prevention strategy known as ABC -- which stands for abstinence, be rigid and use condoms -- ...read full article»
-
Lets Get To Heart Of Coronary Artery Disease
An international consortium has been launched to try to deal coronary artery disease using the latest scientific tools. Funded by the European Commission, the vigour will increase on brand-new advances in genomic science and the understanding of our genes to ...read full article»
-
Mouse Stem Cell Line Advance Suggests Potential For IVF-Incompetent Eggs
Researchers comprise found that mouse oocytes that fail to become fertilized during in vitro fertilization are nevertheless often able of succeeding as "cytoplasmic donors" during a later cloning accelerate using so-called atomic transfer. Although the implications notwithstanding human eggs are ...read full article»
-
New clues for an effective AIDS vaccine
Two subordinate changes in its outer envelope protein could render the AIDS virus unguarded to seizure by the protected set, according to research from Kenya and the Fred Hutchinson Cancer Analyse Center published in PLoS Prescription. The results could provide important ...read full article»
-
Indian Doctor, Assistant Sentenced To Two Years In Prison For Revealing Gender Of Fetuses, Offering Sex-Selective Abortions
An Indian court in the northern state of Haryana on Tuesday sentenced a doctor and his technician to two years in reformatory and fined them about $125 each in requital for performing a gender resolving test in 2001, Reuters reports ...read full article»
-
FDA Approves Labeling Change For VYVANSE CII To Efficacy At 13 Hours Postdose In Children With ADHD
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical business, has announced that the US Food and Drug Delivery (FDA) has approved a change to the prescribing knowledge for its once-daily Notice Deficit Hyperactivity Carfuffle (ADHD) treatment VYVANSE® (lisdexamfetamine ...read full article»